VanEck Biotech ETF (NASDAQ:BBH) versus Mexico Equity & Income Fund (NYSE:MXE) Financial Survey

VanEck Biotech ETF (NASDAQ:BBH) and Mexico Equity & Income Fund (NYSE:MXE) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for VanEck Biotech ETF and Mexico Equity & Income Fund, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VanEck Biotech ETF	0	7	3	0	2.66
Mexico Equity & Income Fund	0	0	0	0	0.00

VanEck Biotech ETF presently has a consensus price target of $162.55, indicating a potential upside of 0.00%. Given VanEck Biotech ETF’s stronger consensus rating and higher probable upside, equities analysts plainly believe VanEck Biotech ETF is more favorable than Mexico Equity & Income Fund.

Dividends

VanEck Biotech ETF pays an annual dividend of $1.25 per share and has a dividend yield of 0.8%. Mexico Equity & Income Fund pays an annual dividend of $0.30 per share and has a dividend yield of 3.4%.

Profitability

This table compares VanEck Biotech ETF and Mexico Equity & Income Fund’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
VanEck Biotech ETF	N/A	N/A	N/A
Mexico Equity & Income Fund	N/A	N/A	N/A

Risk and Volatility

VanEck Biotech ETF has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Mexico Equity & Income Fund has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.

Earnings & Valuation

This table compares VanEck Biotech ETF and Mexico Equity & Income Fund”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Biotech ETF	N/A	N/A	N/A	N/A	N/A
Mexico Equity & Income Fund	-$6.05 million	-6.34	N/A	N/A	N/A

Institutional and Insider Ownership

32.0% of VanEck Biotech ETF shares are held by institutional investors. 6.1% of Mexico Equity & Income Fund shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

VanEck Biotech ETF beats Mexico Equity & Income Fund on 5 of the 8 factors compared between the two stocks.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

About Mexico Equity & Income Fund

Mexico Equity & Income Fund Inc. is a closed ended balanced mutual fund launched and managed by Pichardo Asset Management, S.A. de C.V. The fund invests in the fixed income and public equity markets of Mexico. It also invests some portion in the convertible securities. The fund invests in the stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the Mexbol and MSCI Mexico Index. Mexico Equity & Income Fund Inc. was formed on May 24, 1990 and is domiciled in the United States.